Sucampo Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts quarterly revenue above estimates, shares rise
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
Sucampo Pharma (SCMP) Misses Q1 EPS by 17c, Reiterates FY Guidance
May 3, 2017 6:37 AM EDTSucampo Pharma (NASDAQ: SCMP) reported Q1 EPS of $0.10, $0.17 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $56.3 million versus the consensus estimate of $54.14 million.
Sucampo today reiterated its guidance for the full year ending December 31, 2017. Sucampo expects total revenue of... More
